Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Takara Bio Inc.

Capitalization 138B 865M 756M 683M 653M 1.19B 79.97B 1.23B 8.16B 3.23B 38.21B 3.24B 3.18B P/E ratio 2026 *
-56x
P/E ratio 2027 * 215x
Enterprise value 138B 865M 756M 683M 653M 1.19B 79.97B 1.23B 8.16B 3.23B 38.21B 3.24B 3.18B EV / Sales 2026 *
3.03x
EV / Sales 2027 * 2.82x
Free-Float
38.39%
Yield 2026 *
0.96%
Yield 2027 * 1.05%
Current month-0.09%
1 month+43.07%
3 months+45.80%
6 months+23.36%
Current year+44.15%
1 week 1,146
Extreme 1146
1,148
1 month 951
Extreme 951
1,150
Current year 781
Extreme 781
1,150
1 year 711
Extreme 711
1,150
3 years 711
Extreme 711
1,790
5 years 711
Extreme 711
3,350
10 years 711
Extreme 711
3,535
Manager TitleAgeSince
Chief Executive Officer 62 23/06/2025
Chief Tech/Sci/R&D Officer 66 -
Chief Operating Officer 65 31/03/2020
Director TitleAgeSince
Chairman 63 23/06/2025
Director/Board Member 63 31/05/2022
Director/Board Member 62 31/05/2018
Change 5d. change 1-year change 3-years change Capi.($)
0.00%0.00%+36.10%-34.78% 865M
-0.72%-4.60%-11.02%-8.56% 42.78B
-0.44%-5.67%+11.58%+27.82% 31.5B
-0.24%-3.29%+15.77%+44.41% 29.99B
+1.10%-5.60%-9.21%-16.86% 27.65B
-0.22%-3.60%+143.04%+320.11% 18.8B
-1.32%-6.10%+48.37%+109.92% 13.87B
+1.48%-4.29%+41.67%+158.40% 12.78B
-0.29%-4.80%+21.98%-2.54% 12.39B
-1.59%-3.85%+116.38%+112.00% 11.76B
Average -0.22%-3.78%+41.47%+70.99% 20.24B
Weighted average by Cap. -0.23%-4.05%+28.05%+60.28%

Financials

2026 *2027 *
Net sales 45.52B 285M 249M 225M 215M 392M 26.38B 407M 2.69B 1.07B 12.6B 1.07B 1.05B 48.94B 307M 268M 242M 232M 421M 28.36B 438M 2.89B 1.15B 13.55B 1.15B 1.13B
Net income -2.46B -15.42M -13.48M -12.18M -11.65M -21.19M -1.43B -22.02M -145M -57.65M -681M -57.86M -56.64M 643M 4.03M 3.52M 3.18M 3.04M 5.54M 373M 5.75M 38.01M 15.06M 178M 15.12M 14.8M
Net Debt - -
Logo Takara Bio Inc.
TAKARA BIO INC. is a Japan-based company principally engaged in bio-industry support business and gene medicine business. The Company operates in three business segments. Bioindustry Support segment provides reagents for research (genetic engineering reagents, cell engineering reagents, protein engineering reagents), scientific instruments, contract services and license fees for gene related patents to research institutes, such as universities and companies where biotechnology research and development are conducted. Gene Medicine segment provides gene therapy-related development and sale licensing fees and trial products as an application field of genetic engineering technology and cell engineering technology which is core technology cultivated in development of research reagents. Medical Food and Biotechnology segment provides health food and health food research and development services, license fees for health food related patents, as well as license fees for mushrooms.
Employees
1,779
Date Price Change Volume
13/03/26 1,146.00 ¥ 0.00% 645,800
12/03/26 1,146.00 ¥ 0.00% 470,300
11/03/26 1,146.00 ¥ 0.00% 548,000
10/03/26 1,146.00 ¥ 0.00% 639,800
09/03/26 1,146.00 ¥ 0.00% 1,131,600
Trader
-
Investor
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1,146.00JPY
Average target price
1,900.00JPY
Spread / Average Target
+65.79%

Quarterly revenue - Rate of surprise

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW